Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML

WT1 overexpression is frequently identified in acute myeloid leukemia (AML) and has been reported to be a potential marker for monitoring measurable residual disease (MRD). We evaluated the use of postinduction WT1 MRD level as a prognostic factor, as well as the interaction between postinduction WT...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Juliette, Lambert, Jerome, Thomas, Xavier, Marceau-Renaut, Alice, Micol, Jean-Baptiste, Renneville, Aline, Clappier, Emmanuelle, Hayette, Sandrine, Récher, Christian, Raffoux, Emmanuel, Pigneux, Arnaud, Berthon, Celine, Terré, Christine, Celli-Lebras, Karine, Castaigne, Sylvie, Boissel, Nicolas, Rousselot, Philippe, Preudhomme, Claude, Dombret, Hervé, Duployez, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153044/
https://www.ncbi.nlm.nih.gov/pubmed/34625784
http://dx.doi.org/10.1182/bloodadvances.2021004322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153044/
https://www.ncbi.nlm.nih.gov/pubmed/34625784
http://dx.doi.org/10.1182/bloodadvances.2021004322

Ejemplares similares